For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250605:nRSE6303La&default-theme=true
RNS Number : 6303L AVI Global Trust PLC 05 June 2025
AVI Global Trust plc (the "Company")
AVI Open Letter to Gerresheimer Supervisory Board
Asset Value Investors ("AVI"), the Company's investment manager, has today
published an open letter to the Supervisory Board of Gerresheimer AG. A copy
of the letter can be found on AVI's
(https://www.assetvalueinvestors.com/campaign/gerresheimer-a-shot-of-new-medicine-required/)
website: Gerresheimer - a shot of new medicine required
(https://www.assetvalueinvestors.com/content/uploads/2025/06/AVI-Gerresheimer-Public-Letter-June-2025.pdf)
AVI Global Trust owns 1.2m shares in Gerresheimer AG, equivalent to a 3.5%
stake and fully supports the points set out by AVI in its letter.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCEANKSEAXSEEA